Literature DB >> 3150916

In vitro activities of ofloxacin and four other new quinoline-carboxylic acids against Chlamydia trachomatis.

A Nagayama1, T Nakao, H Taen.   

Abstract

The in vitro activities of five new quinoline-carboxylic acids against 2 reference strains and 45 clinical isolates of Chlamydia trachomatis of genital origin were compared with the activities of minocycline and doxycycline. Ofloxacin was the third most active agent (after the two tetracyclines), followed by ciprofloxacin, NY-198, and AM-833.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3150916      PMCID： PMC175961          DOI： 10.1128/AAC.32.11.1735

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens.

Authors:  W R Bowie; C E Shaw; D G Chan; J Boyd; W A Black
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

2.  Comparison of various McCoy cell treatment procedures used for detection of Chlamydia trachomatis.

Authors:  R T Evans; D Taylor-Robinson
Journal:  J Clin Microbiol       Date:  1979-08       Impact factor: 5.948

3.  In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.

Authors:  L D Liebowitz; J Saunders; G Fehler; R C Ballard; H J Koornhof
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

4.  Failure of norfloxacin to eradicate Chlamydia trachomatis in nongonococcal urethritis.

Authors:  W R Bowie; V Willetts; L Sibau
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

5.  Treatment of nongonococcal urethritis with ciprofloxacin.

Authors:  I W Fong; W Linton; M Simbul; R Thorup; B McLaughlin; V Rahm; P A Quinn
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

6.  In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents.

Authors:  T Kumada; H C Neu
Journal:  J Antimicrob Chemother       Date:  1985-11       Impact factor: 5.790

7.  In vitro and in vivo activity of DL-8280, a new oxazine derivative.

Authors:  K Sato; Y Matsuura; M Inoue; T Une; Y Osada; H Ogawa; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

8.  Treatment of genital chlamydial infection with ofloxacin.

Authors:  L Fransen; D Avonts; P Piot
Journal:  Infection       Date:  1986       Impact factor: 3.553

9.  Antimicrobial activity of U-70138F (paldimycin), roxithromycin (RU 965), and ofloxacin (ORF 18489) against Chlamydia trachomatis in cell culture.

Authors:  W E Stamm; R Suchland
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

10.  Treatment of uncomplicated gonococcal urethritis in men with two dosages of ciprofloxacin.

Authors:  M J Tegelberg-Stassen; J C van der Hoek; L Mooi; J H Wagenvoort; T van Joost; M F Michel; E Stolz
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267
View more
  10 in total

1.  Sparfloxacin in the treatment of males with urethritis.

Authors:  M Tanaka; T Matsumoto; J Kumazawa; A Nagayama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

2.  In vitro activities of doxycycline and enrofloxacin against European Chlamydia psittaci strains from turkeys.

Authors:  P Butaye; R Ducatelle; P De Backer; H Vermeersch; J P Remon; F Haesebrouck
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

3.  Comparison of ofloxacin, gentamicin, and tobramycin concentrations in tears and in vitro MICs for 90% of test organisms.

Authors:  J Richman; H Zolezio; D Tang-Liu
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

4.  Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; B Jürgens-Saathoff; A P Hudson; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

5.  Promising bioadhesive ofloxacin-loaded polymeric nanoparticles for the treatment of ocular inflammation: formulation and in vivo evaluation.

Authors:  Alaa H Salama; Mona M AbouSamra; Ghada E A Awad; Soheir S Mansy
Journal:  Drug Deliv Transl Res       Date:  2020-10-02       Impact factor: 4.617

6.  The inhibitory effect of phosphate on the ligase chain reaction used for detecting Chlamydia trachomatis.

Authors:  T Notomi; Y Ikeda; A Okadome; A Nagayama
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411

7.  Topical ofloxacin compared with gentamicin in the treatment of external ocular infection. Ofloxacin Study Group.

Authors:  A Gwon
Journal:  Br J Ophthalmol       Date:  1992-12       Impact factor: 4.638

Review 8.  Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.

Authors:  J A Balfour; P A Todd; D H Peters
Journal:  Drugs       Date:  1995-05       Impact factor: 9.546

Review 9.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

10.  Improved corneal bioavailability of ofloxacin: biodegradable microsphere-loaded ion-activated in situ gel delivery system.

Authors:  Elshaimaa G Sayed; Amal K Hussein; Khaled A Khaled; Osama A A Ahmed
Journal:  Drug Des Devel Ther       Date:  2015-03-10       Impact factor: 4.162
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.